Product Comparison Charts

Compare multiple products side-by-side and download an Excel spreadsheet to assist in product evaluations and purchasing discussions.

Step 2/3

Drug-Coated Balloons

Drug-coated balloons (DCB), also referred to as drug-eluting balloons, are used to treat peripheral and coronary artery lesions and restenosis. The balloons carry an antiproliferative drug that is delivered to the wall of arteries when the balloon is expanded. The drug helps prevent neointimal hyperplasia caused by vessel trauma from the balloon angioplasty. Find news and video content on DCBs

Last updated on August 14, 2023
Company Product
BD Lutonix 035
BD Lutonix 035
BD Lutonix 018
Medtronic IN.PactAdmiral Drug-Coated Balloon
Medtronic IN.Pact AV Drug-Coated Balloon
Medtronic IN.Pact Pacific Drug-eluting Balloon
Philips Stellarex 0.035" OTW drug-coated angioplasty balloon

Additional Content

Feature | Drug-Eluting Balloons | Kyle Hardner

With a sirolimus-based drug-coated balloon (DCBs) entering the U.S. market, interventional cardiologists treating in ...

Home October 21, 2026
Home
News | Drug-Eluting Balloons

Aug. 21, 2025 — Boston Scientific has initiated the AGENT DCB STANCE trial to assess the safety and effectiveness of the ...

Home August 22, 2025
Home
News | Drug-Eluting Balloons

March 1, 2024 — Boston Scientific Corporation today announced it has received U.S. Food and Drug Administration (FDA) ...

Home March 01, 2024
Home
News | Drug-Eluting Balloons

October 30, 2023 — Boston Scientific Corporation on Friday announced positive 12-month results from the pivotal AGENT ...

Home October 30, 2023
Home
News | Drug-Eluting Balloons

September 14, 2023 — BIOTRONIK announced the two-year-results from the BIOLUX P-III BENELUX all-comers registry ...

Home September 14, 2023
Home
Subscribe Now